Recent Trends in Pharmacology

Atatürk University

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Recent Trends in Pharmacology is an open-access journal published by Atatürk University in Türkiye, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Atatürk University
ISSN
2980-194X
Country
Türkiye
Languages
english
Access
Open access
Articles in DOAJ
40
Declared review time
10 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2024-09-19
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

40

Most recent article

last month

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

36

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy8
Last DOAJ review date
2024-09-19
Added to DOAJ
2024-09-19
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
100%
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Recent trends in pharmacology (Online
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Phytochemicals and Antioxidant Activities
  • Phytochemicals and Antioxidant Activities
  • Acute Kidney Injury Research
  • Neurogenetic and Muscular Disorders Research
  • Chemotherapy-induced organ toxicity mitigation
  • Biochemical effects in animals
  • Biochemical effects in animals
  • Chemotherapy-induced organ toxicity mitigation
Show all subjects (50)
  • Neurogenetic and Muscular Disorders Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Amyotrophic Lateral Sclerosis Research
  • Acute Kidney Injury Research
  • Inflammatory mediators and NSAID effects
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Tryptophan and brain disorders
  • Pharmacological Receptor Mechanisms and Effects
  • Computational Drug Discovery Methods
  • Inflammatory mediators and NSAID effects
  • Amyotrophic Lateral Sclerosis Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Natural product bioactivities and synthesis
  • Tryptophan and brain disorders
  • Sulfur Compounds in Biology
  • Sulfur Compounds in Biology
  • Natural product bioactivities and synthesis
  • Metabolomics and Mass Spectrometry Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Computational Drug Discovery Methods
  • Parkinson's Disease Mechanisms and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Alzheimer's disease research and treatments
  • COVID-19 and Mental Health
  • Retinal Diseases and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Cardiac electrophysiology and arrhythmias
  • COVID-19 Clinical Research Studies
  • Smoking Behavior and Cessation
  • Bone health and osteoporosis research
  • Epilepsy research and treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Cardiac electrophysiology and arrhythmias
  • Antimicrobial Resistance in Staphylococcus
  • Retinal Diseases and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Epilepsy research and treatment
  • Bone health and osteoporosis research
  • Smoking Behavior and Cessation
  • COVID-19 Clinical Research Studies

Keywords (DOAJ)

  • pharmacology
  • antioxidant
  • oxidative stress
  • sepsis
  • pharmacy
  • medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: